The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared to their benign counterparts, the expression in metastatic sites is still not well known. The aim of the current study was to compare the relative expression of the four Notch gene receptors between primary and metastatic sites of ovarian carcinomas. Materials and Methods: Seventeen paired couples of tissues, from primary and metastatic sites of epithelial ovarian cancer, were collected during the cytoreductive surgery. For the study of the gene expression Real-Time Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used. The analysis of the results was performed with the Comparative C T Method (ΔΔCt Method). Results: Notch 3 and 2 were overexpressed compared to Notch 1 and 4 in both primary and metastatic sites. Notch 3 showed the highest differential expression, yet none of the four Notch genes reached statistical significance due to the differences between different samples. Conclusions: The lack of statistical difference in the expression of all four genes between primary and metastatic sites of epithelial ovarian cancer, potentially predicts same treatment response in all intrabdominal tumours and render Notch pathway a suitable and promising candidate for targeted therapies. The high heterogeneity in the expression between the samples, highlights even more the need of personalized therapies. Further studies should include more patients, examine the absolute expression, extend to all histological types, and focus on the Notch intracellular domain expression.
Authors and Affiliations
I. C. Kotsopoulos, A. Papanikolaou, K. T. Papazisis, P. Touplikioti, D. Tsolakidis, A. F. Lambropoulos, B. C. Tarlatzis
Keywords
Related Articles
- EP ID EP663035
- DOI 10.12892/ejgo4354.2019
- Views 81
- Downloads 0
Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival
Summary Purpose of investigation: This study was conducted to elucidate the efficacy and feasibility of surgical management of recurrent gynecological (cervical, endometrial, and ovarian) cancers. Materials and Methods:...
The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors...
High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer
Purpose of Investigation: This study aims to investigate PIBF expression levels in normal, hyperplastic, and endometrioid adenocarcinoma paraffin blocks. The purpose of this study is to determine the PIBF expression leve...
Immunohistochemical analysis of IQGAP2 in ovarian cancer
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immuno...
The association of microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinomas with prognostic factors
Purpose: One of the most important prognostic factors for endometrial carcinoma (EC) is myometrial invasion. Microcystic, elongated, and fragmented (MELF) myometrial invasion (MI) pattern is also important in terms of di...